One-carbon therapeutics AB management at ESMO to discuss the ODIN clinical phase 1/2 trial with potential clinical sites across Europe
One-carbon therapeutics AB is discussing the ODIN trial with several
One-carbon therapeutics AB is discussing the ODIN trial with several
Read the article here.
In preparation and expansion for the upcoming clinical trial, we
Professor Johann de Bono, Head of the Division of Clinical
We look forward to meeting you there!
Read a short story of One-carbon Therapeutics achievements so far
We look forward to showcasing our innovative approach targeting difficult
You can listen to our company presentation on Monday, June
We are excited to discuss our science and program with
Menu bar